Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
20 October 2016Website:
http://www.irhythmtech.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 20:09:06 GMTDividend
Analysts recommendations
Institutional Ownership
IRTC Latest News
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has successfully launched the initial phases of its previously disclosed manufacturing automation plans, marking a significant corporate milestone expected to set the stage for future growth and innovation while also yielding substantial cost savings.
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming Truist Securities MedTech Conference.
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming William Blair 44th Annual Growth Stock Conference.
iRhythm Technologies, Inc. (NASDAQ: IRTC) Q1 2024 Earnings Conference Call on May 2, 2024 at 4:30 PM ET. Participants include Stephanie Zhadkevich, Quentin Blackford, and Brice Bobzien. Conference Call Participants include Allen Gong, Malgorzata Kaczor, Richard Newitter, Marie Thibault, Joanne Wuensch, Kallum Titchmarsh, Nathan Treybeck, David Rescott, Bill Plovanic, Suraj Kalia. Operator Terry welcomes everyone to the call.
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IRhythm Technologies (IRTC) came out with a quarterly loss of $1.26 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.67 per share a year ago.
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President & Chief Executive Officer Brice Bobzien - Chief Financial Officer Conference Call Participants Allen Gong - JPMorgan Malgorzata Kaczor - William Blair David Saxon - Needham Nathan Treybeck - Wells Fargo John Young - Canaccord David Rescott - Baird Suraj Kalia - Oppenheimer Operator Hello and welcome to the iRhythm Technologies Inc. Q3 2023 Earnings Conference Call. My name is Alex, I'll be coordinating the call today.
The heavy selling pressure might have exhausted for iRhythm Technologies (IRTC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the Company will be participating in the upcoming Baird 2023 Global Healthcare Conference and the Morgan Stanley 21st Annual Global Healthcare Conference.
What type of business is iRhythm Technologies?
iRhythm Technologies, Inc. is a digital company serving the healthcare industry. It is a provider of ECG ambulatory monitoring solutions for patients at risk of arrhythmias - portable Zio service biosensors with cloud data analysis. It is a vertically integrated company headquartered in San Francisco, California. The company was founded on September 14, 2006. The company's flagship product is the Zio service platform, which provides a wide range of capabilities for ambulatory heart monitoring. The platform combines a convenient and unobtrusive biosensor for wearing (up to 14 consecutive days) with powerful patented algorithms that turn data from a million heartbeats into clinically actionable information.
What sector is iRhythm Technologies in?
iRhythm Technologies is in the Healthcare sector
What industry is iRhythm Technologies in?
iRhythm Technologies is in the Medical Devices industry
What country is iRhythm Technologies from?
iRhythm Technologies is headquartered in United States
When did iRhythm Technologies go public?
iRhythm Technologies initial public offering (IPO) was on 20 October 2016
What is iRhythm Technologies website?
https://www.irhythmtech.com
Is iRhythm Technologies in the S&P 500?
No, iRhythm Technologies is not included in the S&P 500 index
Is iRhythm Technologies in the NASDAQ 100?
No, iRhythm Technologies is not included in the NASDAQ 100 index
Is iRhythm Technologies in the Dow Jones?
No, iRhythm Technologies is not included in the Dow Jones index
When does iRhythm Technologies report earnings?
The next expected earnings date for iRhythm Technologies is 02 August 2024